Hoon DS - Search Results

1

Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.

Hooda J, Novak M, Salomon MP, Matsuba C, Ramos RI, MacDuffie E, Song M, Hirsch MS, Lester J, Parkash V, Karlan BY, Oren M, Hoon DS, Drapkin R. Hooda J, et al. Among authors: hoon ds. Cancer Res. 2019 Feb 15;79(4):760-772. doi: 10.1158/0008-5472.CAN-18-2297. Epub 2018 Dec 18. Cancer Res. 2019. PMID: 30563893 Free PMC article.

2

Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4.

Morisaki T, Yuzuki DH, Lin RT, Foshag LJ, Morton DL, Hoon DS. Morisaki T, et al. Among authors: hoon ds. Cancer Res. 1992 Nov 1;52(21):6059-65. Cancer Res. 1992. PMID: 1394231

3

Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.

Hoon DS, Banez M, Okun E, Morton DL, Irie RF. Hoon DS, et al. Cancer Res. 1991 Apr 15;51(8):2002-8. Cancer Res. 1991. PMID: 1901239

4

Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.

Hoon DS, Okun E, Banez M, Irie RF, Morton DL. Hoon DS, et al. Cancer Res. 1991 Oct 15;51(20):5687-93. Cancer Res. 1991. PMID: 1913686

5

Interleukin 4 regulates G1 cell cycle progression in gastric carcinoma cells.

Morisaki T, Uchiyama A, Yuzuki D, Essner R, Morton DL, Hoon DS. Morisaki T, et al. Among authors: hoon ds. Cancer Res. 1994 Feb 15;54(4):1113-8. Cancer Res. 1994. PMID: 8313369

6

Transfection of interleukin 2 gene into human melanoma cells augments cellular immune response.

Uchiyama A, Hoon DS, Morisaki T, Kaneda Y, Yuzuki DH, Morton DL. Uchiyama A, et al. Among authors: hoon ds. Cancer Res. 1993 Mar 1;53(5):949-52. Cancer Res. 1993. PMID: 8439968

7

Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.

Fujiwara Y, Chi DD, Wang H, Keleman P, Morton DL, Turner R, Hoon DS. Fujiwara Y, et al. Among authors: hoon ds. Cancer Res. 1999 Apr 1;59(7):1567-71. Cancer Res. 1999. PMID: 10197630

8

Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.

Hoon DS, Bostick P, Kuo C, Okamoto T, Wang HJ, Elashoff R, Morton DL. Hoon DS, et al. Cancer Res. 2000 Apr 15;60(8):2253-7. Cancer Res. 2000. PMID: 10786692

9

Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.

Taback B, Fujiwara Y, Wang HJ, Foshag LJ, Morton DL, Hoon DS. Taback B, et al. Among authors: hoon ds. Cancer Res. 2001 Aug 1;61(15):5723-6. Cancer Res. 2001. PMID: 11479206

10

Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.

Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon DS. Taback B, et al. Among authors: hoon ds. Cancer Res. 2001 Dec 15;61(24):8845-50. Cancer Res. 2001. PMID: 11751407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters